Detalhe da pesquisa
1.
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.
N Engl J Med
; 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38820078
2.
Arterio-occlusive events among patients with chronic myeloid leukemia on tyrosine kinase inhibitors.
Blood
; 143(10): 858-865, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194683
3.
Representation of the population in need for pivotal clinical trials in lymphomas.
Blood
; 142(9): 846-855, 2023 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37363870
4.
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts.
Cell
; 140(5): 652-65, 2010 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-20211135
5.
MpoxRadar: a worldwide MPXV genomic surveillance dashboard.
Nucleic Acids Res
; 51(W1): W331-W337, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37167010
6.
Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase.
Cancer
; 2024 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38804723
7.
Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia.
Cancer
; 130(2): 287-299, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801052
8.
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 401(10388): 1571-1583, 2023 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37116523
9.
Aleukemic Chronic Myeloid Leukemia Without Neutrophilia and Thrombocytosis: A Report From the BCR::ABL1 Pathology Group.
Mod Pathol
; 37(2): 100406, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38104892
10.
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
Blood
; 140(11): 1200-1228, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767897
11.
Treatment of chronic-phase chronic myeloid leukemia in patients randomized to dasatinib or imatinib after suboptimal responses to three months of imatinib therapy: final 5-year results from DASCERN.
Haematologica
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38695123
12.
The interaction between social determinants of health and cervical cancer survival: A systematic review.
Gynecol Oncol
; 181: 141-154, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38163384
13.
Integrative taxonomy of Anaporrhutum mundae sp. nov. (Trematoda: Gorgoderidae), a parasite of the Munda round ray Urotrygon munda (Urotrygonidae) in Costa Rica.
J Helminthol
; 98: e28, 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38516701
14.
Ethno-demographic disparities in humoral responses to the COVID-19 vaccine among healthcare workers.
J Med Virol
; 95(9): e29067, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37675796
15.
Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial.
Blood
; 138(21): 2042-2050, 2021 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407543
16.
A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs.
Blood
; 138(21): 2031-2041, 2021 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407542
17.
Asciminib in chronic myeloid leukemia: a STAMP for expedited delivery?
Haematologica
; 108(11): 2913-2918, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37102603
18.
Risk factors associated with acute kidney injury in a cohort of hospitalized patients with COVID-19.
BMC Nephrol
; 24(1): 140, 2023 05 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37217840
19.
Cardiovascular Toxicities Associated with Tyrosine Kinase Inhibitors.
Curr Cardiol Rep
; 25(4): 269-280, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795308
20.
Chronic myeloid leukaemia.
Lancet
; 398(10314): 1914-1926, 2021 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34425075